Clinical trial
Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT00578240
Study timeline
Study start (unknown)1990-04-01Date precision: month
Registry last updated2026-03-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Rockefeller Universitycollaborator
Flinders Medical Centrecollaborator
University of Southern Californiacollaborator
Gen-Probe, Incorporatedcollaborator
Genentech, Inc.collaborator
General Electriccollaborator
Purdue Universitycollaborator
Biocept, Inc.collaborator
Duke Universitycollaborator
Ikonysiscollaborator
Array Genomicscollaborator
Cold Spring Harbor Laboratorycollaborator
Nodalitycollaborator
Epic Sciencescollaborator
Rutgers Cancer Institute of New Jerseycollaborator
Dana-Farber Cancer Institutecollaborator
Johns Hopkins Universitycollaborator
M.D. Anderson Cancer Centercollaborator
Oregon Health and Science Universitycollaborator
University of California, San Franciscocollaborator
University of Chicagocollaborator
University of Michigancollaborator
University of Washingtoncollaborator
University of Wisconsin, Madisoncollaborator
Fred Hutchinson Cancer Centercollaborator
Broad Institute of MIT and Harvardcollaborator
Weill Medical College of Cornell Universitycollaborator
Institute of Cancer Research, United Kingdomcollaborator
Vitatex Inc.collaborator
Serametrix Corporationcollaborator
Promega Corporationcollaborator
Creatv Microtech, Inc.collaborator
Viatar LLCcollaborator
Massachusetts Institute of Technologycollaborator
Advanced Cell Diagnosticscollaborator
ApoCell, Inc.collaborator
Beckman Coulter GmbHcollaborator
Bioview, Inc.collaborator
Clearbridge BioMedics Pte Ltd., Singaporecollaborator
Cynvenio Biosystemscollaborator
Exosome Diagnostics, Inc.collaborator
Fluxion Biosciencescollaborator
Foundation Medicinecollaborator
Universitätsklinikum Hamburg-Eppendorfcollaborator
Brooklyn ImmunoTherapeutics, LLCcollaborator
Ohio State Universitycollaborator
Palo Alto Research Centercollaborator
Rarecellscollaborator
Silicon Biosystemscollaborator
The Scripps Research Institutecollaborator
University of Minnesotacollaborator
Janssen Diagnostics, LLCcollaborator
University of Regensburgcollaborator
Innocrin Pharmaceuticals Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00578240 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.